Cleo Diagnostics Ltd (COV) — Tangible Net Worth Ratio
Cleo Diagnostics Ltd (COV) has a Tangible Net Worth Ratio of 96.2% as of December 2025. This metric is calculated by deducting intangible assets (AU$333.33K) from net assets (AU$8.83 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Cleo Diagnostics Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cleo Diagnostics Ltd Tangible Net Worth Ratio (2024–2025)
This chart shows how Cleo Diagnostics Ltd's Tangible Net Worth Ratio has changed across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 96.2%, reflecting net assets of AU$8.83 Million with intangible assets of AU$333.33K AUD. For live market cap and overall valuation, see Cleo Diagnostics Ltd market cap and net worth.
Annual Tangible Net Worth Ratio for Cleo Diagnostics Ltd (2024–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Cleo Diagnostics Ltd from 2024 to 2025, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Cleo Diagnostics Ltd (COV) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (AUD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.9% | AU$5.83 Million | AU$358.33K | AU$6.94 Million | ▼ -1.8 pp |
| 2024 | 95.7% | AU$9.39 Million | AU$408.33K | AU$9.88 Million | — |